DNA | Jotup

EQS-News: Exasol Unveils the No-Compromise Analytics Database Unlocking Greater Productivity, Cost-Savings, and Flexibility

Retrieved on:

Thursday, June 1, 2023

Exasol Unveils the No-Compromise Analytics Database Unlocking Greater Productivity, Cost-Savings, and Flexibility

Key Points:

Exasol Unveils the No-Compromise Analytics Database Unlocking Greater Productivity, Cost-Savings, and Flexibility
The issuer is solely responsible for the content of this announcement.
Exasol Unveils the No-Compromise Analytics Database Unlocking Greater Productivity, Cost-Savings, and Flexibility
Nuremberg – May 30, 2023 – Exasol today unveiled its no-compromise analytics database, which delivers more productivity, savings, and flexibility for enterprises to better manage data in the cloud, SaaS, on-premises, or hybrid.
With Exasol, customers can run analytics anywhere their data lives – on-premises, cloud or across multiple clouds – with no rip-and-replace, no need to move data sets, no cost shocks.
Run analytics or machine learning (ML): Exasol's ML capabilities are built directly into the in-memory database engine, to deliver even greater efficiencies and cost savings.

Brain Cancer Canada Awards St. Michael’s Hospital $100,000 Grant for Advanced DNA Sequencer Technology

Retrieved on:

Wednesday, May 31, 2023

Canada, DNA, Unity Health Toronto, Partnership, Cancer, Research, Brain, Brain tumor, Acquisition, Patient, Hospital, BCC, Medical imaging

TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, the country’s leading charitable organization dedicated to brain cancer research, has announced a $100,000 grant to St. Michael’s Hospital, a site of Unity Health Toronto.

Key Points:

TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, the country’s leading charitable organization dedicated to brain cancer research, has announced a $100,000 grant to St. Michael’s Hospital, a site of Unity Health Toronto.
The funds will facilitate the acquisition of a top-of-the-line, next-generation DNA sequencer, technology that will allow St. Michael’s to develop and test innovative new treatment protocols for the toughest forms of brain cancer.
“It will empower us to customize treatments to individual patients, which is a major step towards improved patient outcomes.”
For Brain Cancer Canada, this gift to St. Michael’s brain cancer program is a central element of a push to increase treatment options for brain cancer patients.
“Our goal at BCC is to bring more effective new treatments to patients,” said Angela Scalisi, Chair of Brain Cancer Canada.

Ninepoint Announces Launch of Ninepoint Web3 Innovators Fund and Completion of Change to the Investment Objectives of Ninepoint Bitcoin ETF

Retrieved on:

Wednesday, May 31, 2023

Universe, Blockchain, Intellectual property, DNA, History of the World Wide Web, Culture, Partner (business rank), Movement, Wilson, Organization, Internet, Management, TKN, TSX, Cryptocurrency, Financial services, Bitcoin, Web3, Fund

TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Ninepoint Partners LP, the manager (the “Manager” or “Ninepoint”) of Ninepoint Bitcoin ETF, now Ninepoint Web3 Innovators Fund (the “Fund” or “Ninepoint Web3 Innovators Fund”) (TSX: TKN; TKN.U), is pleased to announce the completion of the previously announced change to the investment objectives of the Fund.

Key Points:

TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Ninepoint Partners LP, the manager (the “Manager” or “Ninepoint”) of Ninepoint Bitcoin ETF, now Ninepoint Web3 Innovators Fund (the “Fund” or “Ninepoint Web3 Innovators Fund”) (TSX: TKN; TKN.U), is pleased to announce the completion of the previously announced change to the investment objectives of the Fund.
Ninepoint believes that Unitholders will enjoy the following benefits from investing in Ninepoint Web3 Innovators Fund:
Convenient Way to Get Exposure to Web3: Ninepoint Web3 Innovators Fund’s investment objectives and strategies offer diversification by providing Unitholders with exposure to widespread innovation in digital assets and the emerging field of Web3.
The Manager believes that this should be a tailwind for Ninepoint Web3 Innovators Fund with its investment objectives and strategies setting it up for long-term success.
Exposure to Enterprise Adoption of Web3: The investment objectives will allow Ninepoint Web3 Innovators Fund to invest in leading companies harnessing Web3 and related technologies to transform their industry or business.

Evaxion Announces Business Update and First Quarter 2023 Financial Results

Retrieved on:

Wednesday, May 31, 2023

“Evaxion continues to make significant progress towards our mission of advancing AI-powered immunotherapies to save lives,” said Per Norlén, Chief Executive Officer of Evaxion.

Key Points:

“Evaxion continues to make significant progress towards our mission of advancing AI-powered immunotherapies to save lives,” said Per Norlén, Chief Executive Officer of Evaxion.
Operating spending for the first quarter of 2023 was offset by the proceeds from issue of shares and exercise of warrants.
Research and Development expenses were $3.9 million for the quarter ended March 31, 2023 as compared to $4.8 million for the quarter ended March 31, 2022.
General and Administrative expenses were $2.5 million for the quarter ended March 31, 2023 as compared to $1.6 million for the quarter ended March 31, 2022.

Aprea Therapeutics to Present at BIO International Convention

Retrieved on:

Tuesday, May 30, 2023

APRE, DNA, Therapy, DDR, ATR, Conference, Pharmaceutical industry

DOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR) pathways, today announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will present a corporate overview at the BIO International Convention, being held in Boston, Massachusetts from June 5-8, 2023.

Key Points:

DOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR) pathways, today announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will present a corporate overview at the BIO International Convention, being held in Boston, Massachusetts from June 5-8, 2023.
“We look forward to presenting at this year’s BIO International Conference as enrollment continues in the Phase 1/2a trial of our lead clinical candidate, ATRN-119, a potential best-in-class ATR inhibitor for treatment of advanced solid tumors harboring defined mutations in DDR pathways,” said Oren Gilad, Ph.D., President and Chief Executive Officer of Aprea.

Vishay Intertechnology Thick Film Power Resistor With Optional NTC Thermistor and PC-TIM Simplifies Designs, Saves Board Space, and Lowers Costs

Retrieved on:

Tuesday, May 30, 2023

DNA, Vishay Intertechnology, Telecommunications, AMS, Temperature, TCR, NTC, NYSE, VSH, AEC, Restriction of Hazardous Substances Directive, Printed circuit board, Electronics

MALVERN, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new AEC-Q200 qualified thick film power resistor in the compact, low profile SOT-227 package for mounting on a heatsink.

Key Points:

MALVERN, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new AEC-Q200 qualified thick film power resistor in the compact, low profile SOT-227 package for mounting on a heatsink.
With the option to integrate an AEC-Q200 qualified, temperature cycle tested NTC thermistor inside the resistor package, the ISOA simplifies designs and saves board space, while its optional PC-TIM streamlines installation in production.
The device’s high power and high energy dissipation simplifies designs and lowers costs by reducing the need for power components.
Serving customers worldwide, Vishay is The DNA of tech.™ Vishay Intertechnology, Inc. is a Fortune 1,000 Company listed on the NYSE (VSH).

George Mason University Receives the CAHME/Canon Solutions America Award for Sustainability in Healthcare Management Education and Practice

Retrieved on:

Tuesday, May 30, 2023

CAHME is an accrediting body for academic programs that offer a professional master’s degree in healthcare management education.

Key Points:

CAHME is an accrediting body for academic programs that offer a professional master’s degree in healthcare management education.
Every year, the organization partners with Canon Solutions America to recognize educational institutions that strive to instill ideals of sustainability and social responsibility in future healthcare leaders.
This award signifies the critical role education plays in inspiring future healthcare leaders to enact positive change incorporating the ideals of cultural competency, community involvement, environmental focus, and sustainability.
“We congratulate George Mason University on this well-deserved recognition.”
For an in-depth look at Mason’s Master of Health Administration program, please visit here .

Wind River Named to Newsweek’s List of the Top 100 Global Most Loved Workplaces for 2023

Retrieved on:

Wednesday, May 31, 2023

Wind River® , a global leader in delivering software for mission-critical intelligent systems, today announced it was named to Newsweek’s Top 100 Global Most Loved Workplaces® list, ranking #13 overall.

Key Points:

Wind River® , a global leader in delivering software for mission-critical intelligent systems, today announced it was named to Newsweek’s Top 100 Global Most Loved Workplaces® list, ranking #13 overall.
“We are thrilled to be named to Newsweek’s prestigious Most Loved Workplaces list, as it showcases the lived experience of Wind River’s cultural attributes of growth mindset; customer focus; and diversity, equity, inclusion, and belonging,” said Wind River interim CEO Bryan LeBlanc.
We are beyond proud to be on the global top 100 list.
Wind River’s commitment to diversity, inclusion, equity, and belonging is more than just words – it’s a priority and strategic imperative.

WEST ELM DEBUTS EXCLUSIVE HOME COLLECTION WITH LIFESTYLE BRAND, RHODE

Retrieved on:

Wednesday, May 31, 2023

Retail, Home Goods, Construction & Property, Interior Design, DNA, Friends, Optimism, Human, WSM, Collection, Williams Sonoma, NYSE, Multimedia, Life, Social media, Interior design

The new collaboration celebrates color throughout all 40-pieces of the collection while embracing layered prints and vintage detail.

Key Points:

The new collaboration celebrates color throughout all 40-pieces of the collection while embracing layered prints and vintage detail.
View the full release here: https://www.businesswire.com/news/home/20230531005700/en/
RHODE + West Elm (Photo: Williams Sonoma)
Founded in 2014 by former college roommates and best friends Phoebe Vickers and Purna Khatau, RHODE is a lifestyle brand that designs for good times, big adventures and a vibrant life.
It was such an incredible process to collaborate with West Elm and bring our signature prints to life with their team.”
Echoing the sentiment, Co-founder Phoebe Vickers added, “In working with West Elm, we truly went back to our origins.
We included a few of our signature prints—bringing the DNA of RHODE to a new medium, which has been incredibly exciting."

Bobbie Reimagines Influence and Announces Second MotherBoard, A Collective of Activist Parents Who Join Forces to Change Parenting Culture and Push Forward Parenting Policies

Retrieved on:

Wednesday, May 31, 2023

Together the MotherBoard will lend their collective voices and take action on the critical issues facing modern parents.

Key Points:

Together the MotherBoard will lend their collective voices and take action on the critical issues facing modern parents.
The MotherBoard – an activist approach to collaborating with celebrities – is composed of parent activists and investors that are ready to create meaningful change in lock-step with Bobbie for Change.
By aligning ourselves with the impactful voices of these modern-day parents, we’re able to create meaningful change together, to bring awareness to the issues and push forth policies that are impacting American parents.
We created Bobbie to change parenting culture and the MotherBoard is a critical pillar of that mission,” said Laura Modi, Bobbie CEO and co-founder, and mom of three.